• LAST PRICE
    18.9100
  • TODAY'S CHANGE (%)
    Trending Up0.1600 (0.8533%)
  • Bid / Lots
    17.6000/ 3
  • Ask / Lots
    19.2000/ 3
  • Open / Previous Close
    18.5500 / 18.7500
  • Day Range
    Low 17.8600
    High 19.1100
  • 52 Week Range
    Low 12.9000
    High 39.1175
  • Volume
    670,452
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 18.75
TimeVolumeALLO
09:32 ET612218.445
09:33 ET489118.13
09:35 ET164218.05
09:37 ET275618.015
09:39 ET41518.01
09:42 ET951718.14
09:44 ET151818.09
09:46 ET157518.01
09:48 ET526918.08
09:50 ET525418.1299
09:51 ET918918.23
09:53 ET230018.145
09:55 ET20018.1131
09:57 ET300018
10:00 ET100017.98
10:02 ET116717.97
10:04 ET672017.93
10:06 ET85517.875
10:08 ET150017.99
10:09 ET380018.07
10:11 ET288018.075
10:13 ET170518.14
10:15 ET76918.0597
10:18 ET210018.1025
10:20 ET167518.175
10:22 ET200018.17
10:24 ET140018.21
10:26 ET100018.3
10:27 ET79918.27
10:29 ET80018.24
10:31 ET132018.29
10:33 ET186318.31
10:36 ET183318.32
10:38 ET640918.34
10:40 ET40018.3
10:42 ET113618.24
10:44 ET70018.17
10:45 ET63618.13
10:47 ET101718.05
10:49 ET400018.155
10:51 ET59018.15
10:54 ET170018.26
10:56 ET101718.3
10:58 ET960818.275
11:00 ET268718.27
11:02 ET10018.32
11:03 ET222018.33
11:05 ET110018.32
11:07 ET191618.33
11:09 ET190018.3
11:12 ET136018.35
11:14 ET117018.35
11:16 ET160718.4
11:18 ET90018.4
11:20 ET120018.4397
11:21 ET120018.53
11:23 ET120018.65
11:25 ET10018.63
11:30 ET491318.62
11:32 ET916018.6202
11:34 ET655018.69
11:36 ET454718.78
11:38 ET91218.79
11:39 ET30018.83
11:41 ET170018.83
11:43 ET20018.805
11:45 ET80018.83
11:48 ET20318.85
11:50 ET50918.89
11:52 ET20018.875
11:54 ET150018.825
11:56 ET89318.865
11:59 ET10018.88
12:01 ET198518.89
12:03 ET142518.85
12:06 ET289618.85
12:08 ET126118.87
12:10 ET685418.99
12:12 ET601318.99
12:14 ET231318.98
12:15 ET109818.975
12:17 ET20018.975
12:19 ET79118.965
12:21 ET210018.89
12:24 ET177518.95
12:26 ET80018.96
12:30 ET80018.97
12:32 ET120018.94
12:33 ET50018.895
12:35 ET408918.905
12:37 ET130018.88
12:39 ET170018.82
12:42 ET188018.84
12:44 ET78918.86
12:46 ET40018.91
12:48 ET230018.83
12:50 ET160018.83
12:51 ET30018.83
12:53 ET10018.8
12:55 ET87518.77
12:57 ET100018.7681
01:02 ET130018.79
01:04 ET126918.8
01:06 ET109618.78
01:09 ET100018.86
01:11 ET70018.87
01:13 ET19218.86
01:15 ET148118.86
01:18 ET83218.92
01:20 ET20018.92
01:26 ET20018.955
01:27 ET10018.949
01:29 ET124018.95
01:31 ET150018.95
01:33 ET30018.965
01:36 ET110418.93
01:38 ET20018.915
01:40 ET70018.93
01:42 ET60018.965
01:44 ET109618.96
01:47 ET10018.96
01:49 ET11018.96
01:51 ET28618.97
01:54 ET91818.94
01:56 ET111918.92
01:58 ET70018.93
02:00 ET259418.91
02:02 ET90419
02:03 ET72018.98
02:07 ET67018.985
02:09 ET271519.02
02:12 ET90019.04
02:16 ET130018.99
02:18 ET197419.01
02:20 ET125618.98
02:23 ET65718.99
02:25 ET125118.99
02:27 ET60018.98
02:32 ET95419.06
02:34 ET97619.07
02:36 ET40019.07
02:38 ET40019.06
02:39 ET588219.1
02:41 ET195219.04
02:43 ET101119.08
02:45 ET40019.08
02:48 ET65019.08
02:50 ET178319.06
02:52 ET154519
02:54 ET120019.03
02:57 ET20019.02
03:01 ET230018.93
03:03 ET269618.94
03:06 ET10018.97
03:08 ET77018.955
03:10 ET273618.95
03:12 ET170318.96
03:14 ET30018.94
03:15 ET168218.96
03:17 ET110018.975
03:19 ET100018.96
03:21 ET120018.945
03:24 ET179918.97
03:26 ET475819
03:28 ET20019
03:30 ET21618.99
03:32 ET247418.99
03:33 ET205018.95
03:35 ET201818.88
03:37 ET158918.86
03:39 ET638718.87
03:42 ET80018.835
03:44 ET353318.82
03:46 ET291018.77
03:48 ET173318.84
03:50 ET146718.83
03:51 ET549618.91
03:53 ET675018.96
03:55 ET1711718.95
03:57 ET835118.9
04:00 ET1177918.91
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesALLO
Allogene Therapeutics Inc
2.7B
-10.1x
---
United StatesTGTX
TG Therapeutics Inc
2.5B
-6.8x
---
United StatesTIL
Instil Bio Inc
2.9B
-24.1x
---
United StatesIOVA
Iovance Biotherapeutics Inc
2.9B
-9.0x
---
United StatesIBRX
Immunitybio Inc
2.4B
-6.6x
---
United StatesAUPH
Aurinia Pharmaceuticals Inc
2.6B
-17.2x
---
As of 2021-12-08

Company Information

Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The Company is engaged in developing a pipeline of multiple allogeneic chimeric antigen receptor (CAR) T cell product candidates utilizing protein engineering, gene editing, gene insertion and advanced T cell manufacturing technologies. Its advanced product candidates, ALLO-501 and ALLO-501A, are engineered allogeneic CAR T cell therapies that target CD19, a protein expressed on the cell surface of B cells and a validated target for B cell driven hematological malignancies. It is also developing engineered allogeneic CAR T cell product candidates for multiple myeloma, clear cell renal cell carcinoma (ccRCC), and other blood cancers and solid tumors. Its lead product candidates include ALLO-501, ALLO-501A, ALLO-715, ALLO-715, ALLO-605, ALLO-316, and ALLO-647.

Contact Information

Headquarters
210 E Grand AveSOUTH SAN FRANCISCO, CA, United States 94080-4811
Phone
650-457-2700
Fax
302-636-5454

Executives

Executive Chairman of the Board
Arie Belldegrun
President, Chief Executive Officer, Co-Founder, Director
David Chang
Co-Founder, Director
Joshua Kazam
Chief Financial Officer
Eric Schmidt
Executive Vice President - Research and Development, Chief Medical Officer
Rafael Amado

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.7B
Revenue (TTM)
$38.4M
Shares Outstanding
142.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.87
Book Value
$7.69
P/E Ratio
-10.1x
Price/Sales (TTM)
69.5
Price/Cash Flow (TTM)
---
Operating Margin
-653.68%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.